AAGL 2021 Classification and Surgical Complications in Women With Endometriosis
AAGL 2021 Classification System And Risk Of Surgical Complications In Women Undergoing Surgery For Endometriosis
1 other identifier
observational
198
1 country
1
Brief Summary
Several classifications exist to describe peri-operative complications including the Clavien-Dindo classification which is easily applicable to laparoscopic removal of endometriosis in all stages and is widely recommended for the evaluation of outcomes of endometriosis surgery. The most widely used staging system is the one reviewed by the American Society of Reproductive Medicine (rASRM) which, however, does not study DIE. In contrast, the ENZIAN score studies the anterior, posterior and lateral compartment of the pelvis and provides more reliable information on the extent of lesions. On the other hand, the rASRM and ENZIAN classification systems expressing the disease burden only indirectly correlate with the risk of postoperative complications and are not good predictors of post-surgical complications \[19\]. There are no studies in the literature evaluating the association of these complications with aspects such as the technical difficulty of surgical removal of endometriosis in relation to the extent of the disease. The study of perioperative complications is essential in endometriosis surgery, so having a classification system capable of predicting complications on the basis of surgical complexity could guide clinical practice and post-operative management of patients with DIE. This study could provide useful elements not only to improve the post-operative outcome of the operated patients, but also to identify preoperatively those pictures of DIE for which the surgeon will have to pay more attention because they have a higher risk of perioperative adverse events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2025
CompletedStudy Start
First participant enrolled
February 1, 2025
CompletedFirst Posted
Study publicly available on registry
February 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 2, 2025
CompletedFebruary 13, 2025
November 1, 2024
29 days
January 10, 2025
February 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association between AAGL staging and the occurrence of peri-operative complications
Occurrence of (one or more) peri-operative complications
within 90 days from surgery
Secondary Outcomes (6)
Association between the AAGL score, ENZIAN classification, r-ASRM stage and the occurrence of peri-operative complications
within 90 days from surgery
Occurrence of peri-operative complications in patients undergoing surgery for DIE compared to patients undergoing surgery for DIE with hysterectomy
within 90 days from surgery
Occurrence of peri-operative complications in patients who underwent preoperative medical therapy compared to patients who did not
within 90 days from surgery
Occurrence of peri-operative complications in patients who underwent peri-operative medical therapy compared to patients who discontinued medical therapy close to surgery
within 90 days from surgery
Occurrence of clinical/radiological recurrence of disease at 24 months in patients who underwent peri-operative medical therapy compared to patients who discontinued medical therapy close to surgery
24 months after surgery
- +1 more secondary outcomes
Eligibility Criteria
Women of childbearing age with endometriosis undergoing complete laparoscopic removal of endometriotic lesions between January 2018 and December 2023 consecutively
You may qualify if:
- years to 55 years;
- Pelvic ultrasound and/or radiological (MRI/ CT scan with rectal insufflation) diagnosis of endometriosis and surgery;
- At least 90 days of follow-up after surgery;
- Acquisition of informed consent for participation in the study and processing of data
You may not qualify if:
- Gynaecological oncology;
- Incomplete resection of macroscopic endometriotic lesions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, 40138, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diego Raimondo, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2025
First Posted
February 13, 2025
Study Start
February 1, 2025
Primary Completion
March 2, 2025
Study Completion
May 2, 2025
Last Updated
February 13, 2025
Record last verified: 2024-11